Bank of Montreal’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,566
Closed -$474K 4046
2023
Q4
$474K Buy
11,566
+4,250
+58% +$156K ﹤0.01% 2542
2023
Q3
$266K Buy
+7,316
New +$285K ﹤0.01% 2898
2021
Q2
Sell
-174
Closed -$14K 4157
2021
Q1
$14K Buy
174
+74
+74% +$6.82K ﹤0.01% 4204
2020
Q4
$10K Hold
100
﹤0.01% 4641
2020
Q3
$14K Sell
100
-21
-17% -$3.5K ﹤0.01% 3979
2020
Q2
$24K Buy
121
+21
+21% +$4.35K ﹤0.01% 3770
2020
Q1
$19K Sell
100
-812
-89% -$175K ﹤0.01% 3266
2019
Q4
$189K Hold
912
﹤0.01% 3187
2019
Q3
$139K Hold
912
﹤0.01% 3123
2019
Q2
$118K Sell
912
-1,443
-61% -$171K ﹤0.01% 3239
2019
Q1
$277K Sell
2,355
-1,105
-32% -$111K ﹤0.01% 2570
2018
Q4
$317K Sell
3,460
-610
-15% -$61.8K ﹤0.01% 2369
2018
Q3
$458K Sell
4,070
-1,135
-22% -$120K ﹤0.01% 2375
2018
Q2
$480K Hold
5,205
﹤0.01% 2359
2018
Q1
$519K Hold
5,205
﹤0.01% 2209
2017
Q4
$488K Buy
5,205
+2,377
+84% +$225K ﹤0.01% 2289
2017
Q3
$288K Hold
2,828
﹤0.01% 2506
2017
Q2
$216K Buy
2,828
+884
+45% +$74.4K ﹤0.01% 2620
2017
Q1
$168K Buy
1,944
+1,922
+8,736% +$138K ﹤0.01% 2564
2016
Q4
$1K Hold
22
﹤0.01% 3961
2016
Q3
$1K Sell
22
-659
-97% -$37.1K ﹤0.01% 3929
2016
Q2
$38K Sell
681
-996
-59% -$50.1K ﹤0.01% 3153
2016
Q1
$70K Buy
1,677
+1,018
+154% +$47.2K ﹤0.01% 2925
2015
Q4
$41K Sell
659
-841
-56% -$43K ﹤0.01% 3110
2015
Q3
$61K Buy
+1,500
New +$86.4K ﹤0.01% 2845

Other funds holding LKFT

Bank of Montreal's LKFT Position: Q1 2024 in Review

Bank of Montreal sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 11,566 shares — an estimated $474K sold.

Bank of Montreal first reported a position in LKFT in Q3 2015 and held it in 25 quarters. The position peaked at $519K in Q1 2018. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • Bank of Montreal reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 11,566 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $474K.
  • Bank of Montreal first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 25 quarters.
  • Bank of Montreal's Lakefront Biotherapeutics American Depositary Shares position peaked at $519K in Q1 2018.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.